Gut Fungi Linked to Pediatric Allergic Disease Development, Landmark Studies Reveal
核心洞察
Two studies in Nature Communications identify gut fungi as key players in immune dysregulation and pediatric allergic diseases, including asthma and atopic dermatitis (搜索).
Analysis of over 2,200 samples from 1,400 infants shows specific fungal species like Malassezia (搜索) and Saccharomycetaceae (搜索) follow distinct developmental trajectories in the first year of life.
Early-life antibiotic exposure was found to disrupt the gut mycobiome, allowing fungal species such as Malassezia (搜索) to flourish and directly affect immunological function.
Two landmark studies jointly published in Nature Communications have revealed that fungi residing in the gut microbiome play a critical role in the development of immune dysregulation and pediatric allergic diseases, opening new avenues for early detection and therapeutic intervention.
The research, drawing on data from the CHILD Cohort Study, assessed over 2,200 samples from more than 1,400 participants during their first year of life, providing an unprecedented window into how the gut mycobiome—the fungal component of the gut microbiome—shapes immune development in early childhood.
"Hundreds of millions of children worldwide are affected by allergic diseases, and the number is growing," said Dr. Stuart Turvey, senior author of one study, investigator at the BC Children's Hospital Research Institute (搜索) (BCCHR), and professor of pediatrics at the University of British Columbia. "A better understanding of what gives rise to these conditions and how we can prevent them would have an enormous benefit for children around the globe."
Fungal Species Follow Distinct Developmental Patterns
The research demonstrated that fungal species in the infant gut develop in specific, predictable ways during the first year of life. Saccharomycetaceae (搜索) showed progressive growth over this period, while Malassezia (搜索) levels decreased over time. These trajectories were not merely incidental—the presence and abundance of certain fungal species correlated with later allergic outcomes.
Notably, Malassezia (搜索) was more commonly identified in infants who went on to develop atopic dermatitis (搜索). The findings suggest that fungi can serve as informative markers of early-life microbial development and may indicate whether a child is at risk for diseases such as atopic dermatitis and food allergy (搜索) by five years of age.
Antibiotic Exposure Disrupts the Gut Mycobiome
The second study directly analyzed how antibiotic exposure affects gut fungi in infants under six months of age. The results showed that antibiotic exposure can increase the levels of certain fungal species, including Malassezia (搜索). When assessed in a mouse model, this fungus appeared to cause an increase in allergic inflammation of both gut and airway immune cells.
"These results reveal a previously unrecognized pathway linking early-life antibiotic exposure to allergic disease risk and show how the developing immune system is shaped by fungi within the gut microbiome during a critical window of development," said Dr. Marie-Claire Arrieta of the Snyder Institute for Chronic Diseases (搜索). "Antibiotics are an essential treatment for young children when needed, but this study shows that there is a previously overlooked effect on the gut mycobiome, allowing species like Malassezia (搜索) to flourish and directly affecting immunological function."
Implications for Biomarker Development and Novel Therapeutics
The dual findings position gut fungi as both potential biomarkers and therapeutic targets. By profiling the fungal composition of an infant's gut microbiome, clinicians may one day identify children at elevated risk for allergic diseases before symptoms emerge. Furthermore, the mechanistic link between specific fungal species and immune dysregulation suggests that modulating the gut mycobiome could represent a novel strategy for preventing or treating conditions such as allergic asthma (搜索), atopic dermatitis (搜索), and food allergies.
The research underscores the need to look beyond bacteria when studying the gut microbiome's influence on human health, highlighting fungi as an overlooked but essential component of early-life immune education.